European Journal of Clinical Investigation

Papers
(The H4-Index of European Journal of Clinical Investigation is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
143
ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function97
Correction to ‘Association Between Exposure to Air Pollution and Blood Lipids in the General Population of Spain’86
Effects of glucagon‐like PEPTIDE‐1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META‐analysis81
Issue Information76
Role of PERK‐mediated pathway in the effect of mild hypothermia after cerebral ischaemia/reperfusion69
Human blood metabolites and risk of severe COVID‐19: A Mendelian randomization study50
Progress and challenges in the symbiosis of AI with science and medicine48
Omega‐3 phospholipids and obesity‐associated NAFLD: Potential mechanisms and therapeutic perspectives44
Clinical predictors of late SARS‐CoV‐2 positivity in Italian internal medicine wards41
Clinical implications of vascular dysfunction in acute and convalescent COVID‐19: A systematic review40
New insights into Covid‐19 disease. Apo‐A1 antibodies are generated after mRNA Covid‐19 vaccination and after Covid‐19 infection36
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS‐CoV‐2 variants36
Hydrogen sulphide: Diabetic cardiomyopathy as the paradigm of its pleiotropic function35
Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?33
Effects of pharmacological inhibition of hyaluronic acid synthesis on experimental endometriosis33
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial33
Social determinants of health and cardiovascular outcomes in patients with heart failure32
Clinical use of controlled oxygenated rewarming of kidney grafts prior to transplantation by ex vivo machine perfusion. A pilot study32
Issue Information30
Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease30
rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings29
Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease28
Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus28
Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease27
Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study27
Combination therapy with an SGLT‐2 inhibitor and finerenone in DKD: Are we there yet?26
0.085952997207642